DCAF5

DCAF5 is the substrate-receptor subunit of a CRL4 (Cullin-4 RING) E3 ubiquitin ligase that enforces protein turnover through a conserved lysine-methylation degron pathway and through quality-control surveillance of chromatin-remodeling complexes (PMID:29691401, PMID:38538798). In the methylation-degron arm, the methyl-lysine reader L3MBTL3 binds methylated lysines on non-histone substrates and recruits CRL4DCAF5 to ubiquitinate and degrade them; this circuit controls DNMT1 (methyl-K142), with the demethylase LSD1 and the reader PHF20L1 opposing degradation to stabilize the substrate (PMID:29691401). The same L3MBTL3-CRL4DCAF5 module, recognizing a shared methylation degron motif, targets E2F1, the pluripotency factor SOX2 (methyl-K42/K117), and the PRC2 catalytic subunit EZH2 (methyl-K20), where LSD1-mediated demethylation and AKT-dependent phosphorylation set an opposing methylation-phosphorylation switch; loss of Dcaf5 in mice causes PRC2 accumulation and increased H3K27 trimethylation (PMID:29691401, PMID:30442713, PMID:38346162). Through SOX2 control, DCAF5 depletion restores self-renewal and pluripotency in LSD1- or PHF20L1-deficient ES cells (PMID:30442713). Independently of the methyl-reader pathway, DCAF5 acts as a quality-control receptor that degrades incompletely assembled, SMARCB1-deficient SWI/SNF complexes; its loss in SMARCB1-mutant cancer cells permits reaccumulation of residual SWI/SNF complexes, restoration of target-locus binding and gene expression, and reversal of the malignant state in vivo (PMID:38538798). The complex is accessible for nuclear targeted degradation, as L3MBTL3-recruiting PROTACs redirect CRL4DCAF5 onto non-natural substrates (PMID:35311258).

1. 2018 High

   Establishing how methylated non-histone proteins are cleared, this work identified DCAF5 as the CRL4 substrate receptor that, via the methyl-lysine reader L3MBTL3, recognizes and degrades methyl-K142 DNMT1, defining a methylation-degron proteolysis axis.

   Evidence Co-IP, knockdown/knockout rescue restoring DNMT1, in vivo L3MBTL3-null mice, and ubiquitination/stability assays

   PMID:29691401

   Open questions at the time

   • Structure of the L3MBTL3-CRL4DCAF5-substrate complex not resolved
   • Methyltransferase generating the DNMT1 K142 mark within this pathway not defined here
   • DCAF5-CUL4 binding interface not biochemically mapped
2. 2018 Medium

   Generalizing the degron, the same study showed E2F1 carries a consensus methylation degron shared with DNMT1 and is degraded through the L3MBTL3-CRL4DCAF5 pathway, indicating the receptor recognizes a motif rather than a single protein.

   Evidence Protein stability and ubiquitination assays, Co-IP, and consensus motif analysis with functional validation

   PMID:29691401

   Open questions at the time

   • E2F1 data secondary to the DNMT1 investigation, lacking dedicated in vivo confirmation
   • Physiological context regulating E2F1 methylation/degradation not established
3. 2018 High

   Linking the pathway to stem-cell identity, methylated SOX2 (K42, K117) was shown to be an L3MBTL3-CRL4DCAF5 substrate, and DCAF5 knockdown restored SOX2 and rescued self-renewal/pluripotency defects of LSD1- or PHF20L1-deficient ES cells.

   Evidence Co-IP, siRNA knockdown, K42/K117 mutagenesis, protein stability assays, and ES cell self-renewal/pluripotency rescue

   PMID:30442713

   Open questions at the time

   • Methyltransferase writing SOX2 K42/K117 not identified
   • Relative contribution of K42 vs K117 not fully partitioned
4. 2024 High

   Extending the degron to a chromatin regulator, methyl-K20 EZH2 was shown to be degraded by L3MBTL3-CRL4DCAF5, with LSD1 demethylation and AKT phosphorylation of S21 forming a methylation-phosphorylation switch; Dcaf5-null mice accumulate PRC2 and H3K27me3.

   Evidence Dcaf5-null and Ezh2 K20R knock-in mice, stability and methylation/phosphorylation assays, Co-IP, and HSC phenotyping

   PMID:38346162

   Open questions at the time

   • Identity of the EZH2 K20 methyltransferase unspecified
   • Whether PRC2 accumulation is fully attributable to direct EZH2 degradation vs indirect effects not isolated
5. 2024 High

   Revealing a methyl-reader-independent role, a genome-wide screen identified DCAF5 as a quality-control E3 receptor that degrades SMARCB1-deficient SWI/SNF complexes, with its loss restoring functional SWI/SNF and reversing the SMARCB1-mutant cancer state.

   Evidence Genome-wide CRISPR screen, DCAF5 depletion across 14 SMARCB1-mutant lines, SWI/SNF Co-IP, ChIP, expression analysis, and mouse xenografts

   PMID:38538798

   Open questions at the time

   • Degron/recognition feature on misassembled SWI/SNF not defined
   • Whether L3MBTL3 or methylation participates in this surveillance not addressed
   • Ubiquitination sites on SWI/SNF subunits not mapped
6. 2022 Medium

   Demonstrating pharmacological tractability, L3MBTL3-recruiting PROTACs co-opted CRL4DCAF5 to degrade non-natural nuclear substrates (FKBP12, BRD2), showing the ligase is functional and accessible for targeted degradation in the nucleus.

   Evidence PROTAC synthesis, cell-based degradation and dose-response assays, and nuclear localization studies

   PMID:35311258

   Open questions at the time

   • Single-lab synthetic-substrate demonstration without in vivo validation
   • Ternary complex structure and degradation efficiency relative to native substrates not established

• How DCAF5 distinguishes its methylation-degron substrates from its SWI/SNF quality-control targets, and whether a single recognition mechanism underlies both, remains unresolved.
• No structural model of DCAF5 substrate recognition
• Whether the two activities use overlapping or distinct interaction surfaces unknown
• Identity of the methyltransferases generating the degron marks not established